AXIM Biotechnologies receives purchase order on its CBD gum, obtains CBD toothpaste patent

AXIM Biotechnologies Inc (OTCQB: AXIM) CEO John Huemoeller tells Proactive Investors yesterday, the cannabinoid research and development has received an initial purchase order of 7,500 boxes from Kannaway, a hemp lifestyle online store, for its nutraceutical chewing gum product.

Huemoeller also revealed the company has obtained a patent to formulate CBD toothpaste, and should have a product released this year.